Hims & Hers Health, Inc. Class A HIMS
NYSE · United States · Health Services
$29.79+1.09 (+3.80%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
SAN FRANCISCO, October 01, 2026--Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced two new clinical experts will join its global medical leadership team, led by Global Chief Medical Officer Pat Carroll, MD. Kultar Garcha, MD, will serve as Chief Medical Officer of the UK and EMEA, and Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, will serve as Chief Medical Officer of Hims Australia. The appointments mark the company’s latest step in strengthen
Key Stats for HIMS Stock52-Week Range: $14 to $65Market Cap: around $6. 9 billionStreet Mean Target: around $31Forward 2-Year Revenue Growth (CAGR): around 30%Forward 2-Year EPS Growth (CAGR): around 18%NTM P/E: around 23xLTM Gross Margin: 69.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
This historic signal says AFRM could be back near annual high levels by October
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.